PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA

PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA

Bibliographic Details
Main Authors:	Yuehua Ding, Minqiu Lu, Bin Chu, Lei Shi, Shan Gao, Qiuqing Xiang, Lijuan Fang, Yutong Wang, XI Liu, Xin Zhao, Mengzhen Wang, Yuan Chen, Sun Kai, LI Bao
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975328.40621.c2

Similar Items

2142
by: Rebecca Namenek Brouwer, et al.
Published: (2017-09-01)

GNA11 variants identified in patients with hypercalcemia or hypocalcemia
by: Howles, S, et al.
Published: (2023)

Severe Hypocalcemia due to Denosumab in Metastatic Prostate Cancer
by: Mohammed Muqeet Adnan, et al.
Published: (2014-01-01)

Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
by: Swati Rajput, et al.
Published: (2023-02-01)

Humoral hypercalcemia of pregnancy treated with bisphosphonates
by: Ronit Koren, et al.

Clinical characteristics and prognostic significance of immunoglobulin isotype switch in patients with multiple myeloma
by: Minqiu Lu, et al.
Published: (2023-04-01)

PB1981: EFFICACY AND SAFETY OF DENOSUMAB IN PATIENTS WITH MULTIPLE MYELOMA
by: S. Bougherira, et al.
Published: (2022-06-01)

Denosumab and bisphosphonates: different mechanisms of action and effects.
by: Baron, R, et al.
Published: (2011)

Denosumab as the Treatment of Recalcitrant Tuberculous Pleural Effusion-Associated Hypercalcemia
by: Afdhal Afiq Abd Jalil, et al.
Published: (2021-01-01)

Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
by: Nesbit, M, et al.
Published: (2013)

Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery
by: Abigail M. Schmucker, et al.
Published: (2020-01-01)

Severe, Symptomatic Hypocalcemia due to Denosumab Administration: Treatment and Clinical Course
by: Jarred Strickling, et al.
Published: (2019-04-01)

Pre-mobilization platelet count predicts stem cell yield during mobilization in patients with multiple myeloma
by: Yuan Chen, et al.
Published: (2023-01-01)

Use of bisphosphonates for hypercalcemia in a child with alveolar rhabdomyosarcoma
by: Funda Corapçioğlu, et al.
Published: (2008-06-01)

Association of Hypercalcemia Before Treatment With Hypocalcemia After Treatment in Dogs With Primary Hyperparathyroidism
by: J.D. Dear, et al.
Published: (2017-03-01)

P972: RISK-BENEFIT RATIO OF PERCUTANEOUS KYPHOPLASTY AND PERCUTANEOUS VERTEBROPLASTY IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA WITH VERTEBRAL FRACTURE: A SINGLE-CENTER RETROSPECTIVE STUDY
by: Qiuqing Xiang, et al.
Published: (2023-08-01)

Hypercalcemia in metastatic parathyroid carcinoma followed by hypocalcemia after resection: A case report
by: Takuya Ohashi, et al.
Published: (2023-08-01)

Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report
by: Abdallah Roukain, et al.
Published: (2022-01-01)

Hypocalcemia in Patients With Osteoporosis and Normal Renal Function, Treated With Denosumab, a Retrospective Analysis
by: Zouheir Ibrahim Bitar, et al.
Published: (2024-01-01)

Detection of A2142G, A2142C and A2143G clarithromycin mutations in Helicobacter pylori in Alexandria University Pediatric Hospital
by: Nancy Attia, et al.
Published: (2022-05-01)

Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia
by: Suna Kılınç, et al.
Published: (2020-08-01)

Bisphosphonate-resistant hypercalcemia in a rare case of paraneoplastic PTH secretion
by: Anna Y. Groysman, et al.
Published: (2022-12-01)

An interesting case of bisphosphonate resistant hypercalcemia in acute myelogenous leukemia (AML)
by: Sara M. Cohen, et al.
Published: (2022-12-01)

Denosumab for Breast Cancer with Bone Metastases-Induced Hypercalcemia Complicated with Acute Renal Failure
by: Chen-Yu Kuo, et al.
Published: (2015-06-01)

Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review
by: Christina F. Marlow, et al.
Published: (2018-01-01)

Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
by: Jiaqi Wu, et al.
Published: (2018-08-01)

Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study
by: Kazuyo Nakamura, et al.
Published: (2024-02-01)

Denosumab-induced hypocalcemia post bariatric surgery—a severe and protracted course: a case report
by: Mohd Hazriq Awang, et al.
Published: (2023-03-01)

The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01)

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report
by: Ye-In Oh, et al.
Published: (2024-05-01)

Hypocalcemia and Hypophosphatemia following Concurrent Denosumab Injection and Ferric Carboxymaltose Infusion in a Patient with Normal Renal Function
by: Naomi Szwarcbard, et al.
Published: (2024-01-01)

Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis
by: Liang Dong, et al.
Published: (2024-01-01)

Case series: Osteonecrosis of the jaw related to denosumab preceded by bisphosphonates in cancer and osteoporotic patients
by: Devie Falinda, et al.
Published: (2022-04-01)

PB2142: CLINICAL CHARACTERISTICS AND OUTCOMES OF NEWLY DIAGNOSED PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED LYMPHOMA ADMINISTERED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
by: C. Wang, et al.
Published: (2022-06-01)

A Case of Multiple Myeloma Presenting With Resistant Hypercalcemia
by: Zeki Kemeç, et al.
Published: (2022-10-01)

Detection of A2143G, A2142C, and A2142G Point Mutations with Real-Time PCR in Stool Specimens from Children Infected with <i>Helicobacter pylori</i>
by: Nesrin Gareayaghi, et al.
Published: (2022-08-01)

Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population
by: Dershem, R, et al.
Published: (2020)

Denosumab as a bridge to surgery in a patient with severe hypercalcemia due to primary hyperparathyroidism in the setting of renal dysfunction
by: Remya Rajan, et al.
Published: (2019-01-01)

Bisphosphonates--mechanisms of action in multiple myeloma.
by: Shipman, C, et al.
Published: (2000)

Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature
by: Ravinder D. Bhanot, et al.
Published: (2019-01-01)